Alzheimer’s Agitation Study Now Enrolling
September 3, 2026 | Chandler, AZ — TrialSphere Clinical Research is now enrolling adults ages 55–90 for an Alzheimer’s Agitation Study evaluating an investigational study treatment for agitation associated with Alzheimer’s disease.
Migraine Prevention Study Now Enrolling
July 31, 2026 | Chandler, AZ — TrialSphere Clinical Research is now enrolling adults ages 18–64 for a migraine prevention study evaluating potential new preventive treatment options.
Acute Migraine Treatment Study Now Enrolling
July 14, 2026 | Chandler, AZ — TrialSphere Clinical Research is enrolling adults ages 18–75 for an Acute Migraine Treatment Study in Arizona. Participants may qualify if they have a history of migraine and experience 2–10 moderate or severe migraine attacks per month.
Early Cognitive Decline Study Now Enrolling
May 21, 2026 | Chandler, AZ — Adults ages 55–85 experiencing early memory or cognitive changes may qualify for TrialSphere Clinical Research’s Early Cognitive Decline Study. Learn more about eligibility requirements and enrollment opportunities at https://trialsphereaz.com/research-studies/
